Annie is the affiliate Medical Director for AbbVie Taiwan since 2019, leading Medical Affairs and has a solid broad spectrum of functional competencies in pharmacovigilance, research/clinical operation in real-world evidence generation, and MSL infield excellence.   With unique bilateral career paths in both medical and commercial, professional experiences had recognized via robust track records in launching revolutionary breakthrough therapy and received various awards in corporate and regional level due to her strong business acumen, passionate & visionary leadership.

Prior to AbbVie, Annie was the associate medical director at Sanofi Taiwan & Hong Kong, with vast experience for 10+ years in BMS, Bayer and Novartis in medical and commercial specializing in new product launches across Immunology, Oncology, Hematology, Ophthalmology and Neurosciences.  Sheobtained PhD degree from National Taiwan University in department of biochemistry specializing in enzyme kinetics and anti-bacterial drug discovery; had continued her post-doctoral fellowship in department of pharmacology, school of Medicine at Yale University in anti-cancer pre-clinical and clinical research resulted prominent peer-reviewed publications.